C4 Therapeutics (CCCC) Other Accumulated Expenses (2019 - 2022)

C4 Therapeutics' Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $309000.0 for Q1 2022.

• In Q1 2022, Other Accumulated Expenses fell 65.16% year-over-year to $309000.0; the TTM figure through Mar 2022 stood at $309000.0 (down 65.16% YoY), while the FY2021 annual figure was $413000.0, down 11.94% from the prior year.
• Other Accumulated Expenses was $309000.0 for Q1 2022 at C4 Therapeutics, down from $413000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $887000.0 in Q1 2021 to a low of $164000.0 in Q3 2020.
• Historically, Other Accumulated Expenses has averaged $370750.0 across 4 years, with a median of $294500.0 in 2019.
• The sharpest annual moves came in 2020 and 2022: Other Accumulated Expenses soared 67.5% in 2020, then plunged 65.16% in 2022.
• A 4-year view of Other Accumulated Expenses shows it stood at $280000.0 in 2019, then jumped by 67.5% to $469000.0 in 2020, then decreased by 11.94% to $413000.0 in 2021, then fell by 25.18% to $309000.0 in 2022.
• The last three Other Accumulated Expenses figures came in at $309000.0 (Q1 2022), $413000.0 (Q4 2021), and $201000.0 (Q3 2021), per Business Quant data.